| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 07/27/2006 | WO2006078358A2 Antimicrobial melamine resin and products |
| 07/27/2006 | WO2006078320A2 Methods for manufacturing delivery devices and devices thereof |
| 07/27/2006 | WO2006078282A2 Compositions and systems for forming crosslinked biomaterials and associated methods of preparation and use |
| 07/27/2006 | WO2006078253A1 Method of reclaiming drug compound osi-7904 from liposomal drug manufacturing stream |
| 07/27/2006 | WO2006078242A1 Zero cycle molding systems, methods and apparatuses for manufacturing dosage forms |
| 07/27/2006 | WO2006078241A1 Effervescent and effervescent-dispersion compositions for medicaments and methods of use thereof |
| 07/27/2006 | WO2006078059A1 Emulsified composition for dilution and cancer vaccine composition |
| 07/27/2006 | WO2006077857A1 Method for coating particle with lipid film |
| 07/27/2006 | WO2006077856A1 Injection for mastitis |
| 07/27/2006 | WO2006077742A1 Skin needle producing device and skin needle producing method |
| 07/27/2006 | WO2006077724A1 Cancer vaccine preparation |
| 07/27/2006 | WO2006077494A2 A process for preparing solid dosage forms for extended-release of biguanide and sulfonylurea |
| 07/27/2006 | WO2006077492A1 Sustained release oral dosage forms of gabapentin |
| 07/27/2006 | WO2006077429A1 Anthelmintic composition |
| 07/27/2006 | WO2006077398A2 Microcapsule |
| 07/27/2006 | WO2006077394A2 Formulation |
| 07/27/2006 | WO2006077362A1 Pharmaceutical lipid compositions |
| 07/27/2006 | WO2006077309A1 Injectable pharmaceutical composition containing a catecholamine and a peptidic hormone |
| 07/27/2006 | WO2006077256A1 Metal containing composite materials |
| 07/27/2006 | WO2006077212A1 Use of oxycodone for treating visceral pain |
| 07/27/2006 | WO2006076951A1 Pharmaceutical polymer composition for oral controlled-release delivery of terbutaline sulfate |
| 07/27/2006 | WO2006076891A2 Method and device for encapsulating materials in liposomes comprising a freely adaptable membrane structure |
| 07/27/2006 | WO2006076854A1 Combination medication for malignant tumors and application |
| 07/27/2006 | WO2006076844A1 Traditional chinese medicament for treating injuries from falls, rheumatism and ostealgia and method for manufacture thereof |
| 07/27/2006 | WO2006062581A3 Delivery of therapeutic rnai agents for treating restenosis |
| 07/27/2006 | WO2006057952A3 Small particle copper pyrithione |
| 07/27/2006 | WO2006055352A3 Methods of treating cancer with lipid-based platinum compound formulations administered intraperitoneally |
| 07/27/2006 | WO2006053006A9 Retinoid solutions and formulations made therefrom |
| 07/27/2006 | WO2006050246A3 Formulations of water insoluble or poorly water soluble drugs in lipidated glycosaminoglycan particles, their manufacturing and their use for diagnostics and therapy |
| 07/27/2006 | WO2006041922A3 Agents and methods for administration to the central nervous system |
| 07/27/2006 | WO2006040119A3 Medicament and system for the percutaneous administration of medicaments |
| 07/27/2006 | WO2006039268A3 Pharmaceutical formulations containing vitamin e tpgs molecules that solubilize lipophilic drugs without significant efflux inhibition, and use of such formulations |
| 07/27/2006 | WO2006038080A8 Contact lens package solution |
| 07/27/2006 | WO2006026458A8 Compositions and methods for activating protein synthesis and deactivating catabolic processes in skeletal muscle |
| 07/27/2006 | WO2006017044A3 Topical antiviral formulations |
| 07/27/2006 | WO2005123151A3 Device for releasing an active ingredient and piece of jewelry embodied to give off a scent |
| 07/27/2006 | WO2005122729A3 An iron sequestering antimicrobial composition |
| 07/27/2006 | WO2005118166A3 Pharmaceutical composition containing irbesartan |
| 07/27/2006 | WO2005110483A3 Use of targeted oxidative therapeutic formulation in bone regeneration |
| 07/27/2006 | WO2005107722A3 Directly compressible tricalcium phosphate |
| 07/27/2006 | WO2005107705A3 Extended therapeutic effect ocular implant treatments |
| 07/27/2006 | WO2005089725A3 Capsule for receiving at least one pharmaceutical composition, in particular for powder inhalators |
| 07/27/2006 | WO2005082416A3 Antimicrobial preservatives to achieve multi-dose formulation using beta-cyclodextrins for liquid dosage forms |
| 07/27/2006 | WO2005077332A3 Stable sustained-release oral dosage forms of gabapentin and process for preparation thereof |
| 07/27/2006 | WO2005051871A9 Implantable sensors and implantable pumps and anti-scarring agents |
| 07/27/2006 | WO2005013906A3 pH-RESPONSIVE FILM FOR INTRAVAGINAL DELIVERY OF A BENEFICIAL AGENT |
| 07/27/2006 | WO2004048432A3 Preparation of polyphosphazene microspheres |
| 07/27/2006 | US20060167722 System and method for adaptive drug delivery |
| 07/27/2006 | US20060167435 Transscleral drug delivery device and related methods |
| 07/27/2006 | US20060167265 Process for making amlodipine, derivatives thereof, and precursors therefor |
| 07/27/2006 | US20060167147 Metal-containing composite materials |
| 07/27/2006 | US20060167116 Solubilising polysaccharides substituted with dydrophilic and hydrophobic groups |
| 07/27/2006 | US20060167103 Methods of treating cancer with HDAC inhibitors |
| 07/27/2006 | US20060167100 Orodispersible pharmaceutical composition of an antithrombotic compound |
| 07/27/2006 | US20060167084 Delta-9-THC compositions and methods for treating symptoms associated with multiple sclerosis |
| 07/27/2006 | US20060167073 Liquid pharmaceutical formulations of palonosetron |
| 07/27/2006 | US20060167071 Liquid pharmaceutical formulations of palonosetron |
| 07/27/2006 | US20060167069 Pharmaceutical composition of metaxalone with enhanced oral bioavailability |
| 07/27/2006 | US20060167064 Pharmaceutical liquid composition containing pyridone derivative |
| 07/27/2006 | US20060166976 Compositions and methods for treating or preventing convulsions or seizures |
| 07/27/2006 | US20060166970 Non-nucleosidic inhibitors of reverse transcriptase as antagonists of cell proliferation and inducers of cell differentiation |
| 07/27/2006 | US20060166959 Pharmaceutical compositions based on azetidine derivatives |
| 07/27/2006 | US20060166958 Crystalline amoxicillin trihydrate powder |
| 07/27/2006 | US20060166956 Use of anecortave acetate for the protection of visual acuity in patients with age related macular degeneration |
| 07/27/2006 | US20060166953 Ciclesonide-containing sterile aqueous suspension |
| 07/27/2006 | US20060166943 Microbicidal pyrimidine or triazine for preventing sexual hiv transmission |
| 07/27/2006 | US20060166938 Method of treatment using bisphosphonic acid |
| 07/27/2006 | US20060166937 Bisphosphonates for the treatment of atherosclerosis and device comprising them |
| 07/27/2006 | US20060166903 Phosphocholine linked prodrug derivatives |
| 07/27/2006 | US20060166879 Treatment of conditions associated with the presence of macromolecular aggregates, particularly ophthalmic disorders |
| 07/27/2006 | US20060166872 Fp receptor antagonists or pgf2 alpha antagonists for treating menorrhagia |
| 07/27/2006 | US20060166871 Medical compositions containing ghrelin |
| 07/27/2006 | US20060166859 Compounds and compositions for delivering active agents |
| 07/27/2006 | US20060166344 Bacterial outer memberane vesicles |
| 07/27/2006 | US20060166325 Glial cell line-derived neurotrophic factor receptor |
| 07/27/2006 | US20060165987 Stealthy polymeric biodegradable nanospheres and uses thereof |
| 07/27/2006 | US20060165816 Herbal compositions useful as chemopreventive and therapeutic agents |
| 07/27/2006 | US20060165810 Controlled release from block co-polymer worm micelles |
| 07/27/2006 | US20060165809 Oral pharmaceutical formulation in the form of a plurality of microcapsules for prolonged release of active principle(s) with slow solubility |
| 07/27/2006 | US20060165808 Microcapsules for the delayed, controlled release of perindopril |
| 07/27/2006 | US20060165807 Oral pharmaceutical formulation in the form of aqueous suspension for modified release of active principle(s) |
| 07/27/2006 | US20060165806 Nanoparticulate candesartan formulations |
| 07/27/2006 | US20060165804 Polymer compositions for administration to animals |
| 07/27/2006 | US20060165803 Pharmaceutical compositions of sertaconazole for vaginal use |
| 07/27/2006 | US20060165802 Medium containing water with increased viscosity, method for production and use thereof |
| 07/27/2006 | US20060165801 Hydrous gel and production process and use of the hydrous gel |
| 07/27/2006 | US20060165800 Short duration depot formulations |
| 07/27/2006 | US20060165799 Bone-filling composition for stimulating bone-forming and bone-consolidation comprising calcium sulfate and viscous biopolymers |
| 07/27/2006 | US20060165798 Oral osmotic dosage form having a high flux membrane |
| 07/27/2006 | US20060165797 Dosage form for treating gastrointestinal disorders |
| 07/27/2006 | US20060165796 Extended release formulation of levetiracetam |
| 07/27/2006 | US20060165795 Medicinal compositions comprising a core and a film based on modified cellulose derivatives |
| 07/27/2006 | US20060165794 Spheroids, preparation method thereof and pharmaceutical compositions |
| 07/27/2006 | US20060165793 Pharmaceutical preparation to be dispersed before administration |
| 07/27/2006 | US20060165792 Controlled release oxycodone compositions |
| 07/27/2006 | US20060165791 Oral dosage form prepared by forming granules comprising oxycodone hydrochloride, alkyl cellulose and polymethacrylate, and drying said granules; improving efficiency and quality of pain management |
| 07/27/2006 | US20060165790 Multiparticulates |
| 07/27/2006 | US20060165789 Lercanidipine modified release compositions |
| 07/27/2006 | US20060165788 Lercanidipine pH dependent pulsatile release compositions |
| 07/27/2006 | US20060165787 Ceramic structures for controlled release of drugs |